Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pollen-Enhanced Bionic Mechanoreceptor Induced by Asymmetric Ionic Convection in Hydrogel for Sensory-Augmented Prostheses.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Genetic Associations Between Gastrointestinal Diseases and Chronic Kidney Disease: An Integrated Mendelian Randomization and Bioinformatics Analysis.

Iranian journal of kidney diseases·2026
Same author

Unveiling clinical decision-making in pediatric surgery: how frontline staff perform and what shapes their skills.

BMC medical education·2026
Same author

Impaired Midkine/Treg Signaling Contributes to Pathogenesis of Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

BMAL1 regulates circadian rhythms via phase separation-mediated transcriptional hub formation.

Signal transduction and targeted therapy·2026
Same author

[A Review of Archaeological Studies on Dento-maxillofacial Deformities].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

Related Experiment Video

Updated: Nov 18, 2025

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
08:49

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

15.0K

Engineered FnCas12a with enhanced activity through directional evolution in human cells.

Xiexie Liu1, Xiaoyu Liu1, Chenchen Zhou1

  • 1State Key Laboratory and Key Laboratory of Vision Science, Ministry of Health and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

The Journal of Biological Chemistry
|February 10, 2021
PubMed
Summary

Researchers developed a novel screening system to enhance CRISPR-Cas12a gene editing. This system identified a new variant, eaFnCas12a, with significantly improved DNA cleavage activity for genome editing applications.

Keywords:
FnCas12aPAMRS1activityvariant

More Related Videos

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
08:29

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Published on: October 4, 2024

1.1K
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

2.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens
08:49

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

15.0K
Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
08:29

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Published on: October 4, 2024

1.1K
Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
10:46

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

2.1K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies

Background:

  • CRISPR-Cas12a systems are powerful tools for genome manipulation.
  • Limitations include low cleavage efficiency and strict protospacer adjacent motif (PAM) requirements, hindering therapeutic applications.

Purpose of the Study:

  • To develop a system for identifying novel FnCas12a variants with enhanced DNA cleavage activity.
  • To engineer variants with a broader target selection spectrum for improved genome editing.

Main Methods:

  • A directional evolution and screening system was established in human cells.
  • Site-directed mutagenesis was employed to engineer eaFnCas12a variants.
  • Assessed cleavage activity of wild-type (WT) FnCas12a, eaFnCas12a, and engineered variants.

Main Results:

  • Identified IV-79 (eaFnCas12a), a variant with superior DNA cleavage activity compared to WT FnCas12a.
  • Engineered eaFnCas12a variants, including eaFnCas12a-RR, demonstrated 3.28- to 4.04-fold improved activity.
  • Demonstrated efficacy in correcting the RS1 mutation linked to X-linked retinoschisis.

Conclusions:

  • The developed screening system successfully identified highly active FnCas12a variants.
  • eaFnCas12a and its engineered forms offer enhanced performance for genome editing.
  • These variants hold promise for therapeutic applications requiring efficient gene correction.